Literature DB >> 8963664

Roles of dopamine D1 receptors in delta 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain.

A Miyamoto1, T Yamamoto, M Ohno, S Watanabe, H Tanaka, S Morimoto, Y Shoyama.   

Abstract

We examined whether administration of delta 9-tetrahydrocannabinol (THC) induces the expression of Fos protein or not in the rat brain. A single administration of 3.2 and 10 mg/kg THC produced a dose-dependent and significant increase in Fos-immunoreactive cells in the striatum, particularly in its dorsomedial portions. The peak increase was reached 2 h after THC treatment and was absent at 8 h. Fos induction was also observed in the nucleus accumbens after administration of 10 mg/kg THC. However, in the globus pallidus, hippocampus and substantia nigra pars reticula, abundant in cannabinoid receptors, there were few or no Fos-immunoreactive cells induced by 10 mg/kg THC. SCH-23390, a selective dopamine D1 receptor antagonist, at 0.32 mg/kg produced a significant block of the effects of THC on Fos expression in the striatum and the nucleus accumbens. Administration of 100 mg/kg (-)-sulpiride, a selective dopamine D2 receptor antagonist, failed to block the effect of THC on Fos expression in both the striatum and the nucleus accumbens. These findings indicate that THC induces the expression of Fos protein and that this expression is mediated at least by dopamine D1 receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8963664     DOI: 10.1016/0006-8993(95)01352-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

2.  Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.

Authors:  S M Todd; J C Arnold
Journal:  Br J Pharmacol       Date:  2015-11-18       Impact factor: 8.739

Review 3.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

4.  Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.

Authors:  Mohini Ranganathan; R Andrew Sewell; Michelle Carbuto; Jacqueline Elander; Ashley Schnakenberg; Rajiv Radhakrishnan; Brian Pittman; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2014-01-15       Impact factor: 4.530

5.  Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

Authors:  Deepak Cyril D'Souza; Gabriel Braley; Rebecca Blaise; Michael Vendetti; Stephen Oliver; Brian Pittman; Mohini Ranganathan; Savita Bhakta; Zoran Zimolo; Thomas Cooper; Edward Perry
Journal:  Psychopharmacology (Berl)       Date:  2008-01-29       Impact factor: 4.530

Review 6.  Brain regional differences in CB1 receptor adaptation and regulation of transcription.

Authors:  M F Lazenka; D E Selley; L J Sim-Selley
Journal:  Life Sci       Date:  2012-08-24       Impact factor: 5.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.